Search hospitals > Wisconsin > Franklin
Ascension Saint Francis - Reiman Cancer Center
Claim this profileFranklin, Wisconsin 53132
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
50 reported clinical trials
5 medical researchers
Summary
Ascension Saint Francis - Reiman Cancer Center is a medical facility located in Franklin, Wisconsin. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Breast cancer, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Ascension Saint Francis - Reiman Cancer Center is involved with conducting 50 clinical trials across 172 conditions. There are 5 research doctors associated with this hospital, such as Jonathan S. Treisman, Francis J. Cuevas, Shannon Offerman, and Ranveer Nand.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage II
Stage I
2Breast Cancer
Global LeaderHER2 positive
ER positive
HER2 negative
Top PIs
Jonathan S. TreismanAscension Saint Elizabeth Hospital6 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
15 reported clinical trials
32 drugs studied
Francis J. CuevasAscension Southeast Wisconsin Hospital - Elmbrook Campus8 years of reported clinical research
Studies Colorectal Cancer
Studies Lung Cancer
11 reported clinical trials
24 drugs studied
Shannon OffermanAscension Southeast Wisconsin Hospital - Elmbrook Campus6 years of reported clinical research
Studies Cervical Adenocarcinoma
Studies Parotid Gland Cancer
9 reported clinical trials
29 drugs studied
Ranveer NandAscension Columbia Saint Mary's Hospital - Milwaukee3 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
8 reported clinical trials
19 drugs studied
Clinical Trials running at Ascension Saint Francis - Reiman Cancer Center
Breast Cancer
Lung Cancer
Breast cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Parotid Gland Cancer
Cancer
Plasma Cell Neoplasm
ALK Gene Rearrangement
Prostate Adenocarcinoma
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ascension Saint Francis - Reiman Cancer Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.